Published By : 25 Jan 2016 | Published By : QYRESEARCH
The American College of Cardiology states that in 2012, there were 78,000 people with sick sinus syndrome and by the year 2060 this figure is projected to rise to 172,000. In Asia Pacific as well, conditions associated with atrioventricular blockage have been increasing especially among patients suffering from coronary heart diseases. At present, an estimated 4 million people are fitted with a pacemaker or other cardiac rhythm management device on a global level, and over 700,000 new implants are fitted each year. This indicates that the worldwide market for cardiac pacemakers is definitely on the path of rapid development.
One of the most significant factors fueling the demand for cardiac pacemakers is the rising number of people above the age of 65. The US Census Board has revealed at presently, people above the age of 65 years account for 13 per cent of the total population, which will rise to 20 per cent by 2030. On a global scale, the World Health Organization has stated that by the year 2050, the number of geriatrics will rise to 1.5 billion. Keeping this in mind, a key factor that will drive the global cardiac pacemaker market is the growing geriatric population in Germany and Japan.
Pacemakers have been an essential device for people with irregular heart activity or arrhythmic heart beats for a very long time. However, even with their immense effectiveness, there have been rising concerns over the actual surgical procedure to place the device under the skin by making an incision in the upper chest and the wired connection between the heart muscle and the device – this connection is what gives the much needed thrust to control heart rhythms.
Technological advances, however, have been addressing such issues in recent times, making procedures as minimally invasive as possible and developing transvascular procedures.